Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.8K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.8K
Introduction to z Scores01:06

Introduction to z Scores

11.4K
A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
11.4K
Introduction to z Scores01:05

Introduction to z Scores

1.4K
A z score (or standardized value) is measured in units of the standard deviation. It indicates how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
1.4K
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

19.7K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
19.7K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

216
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
216

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia.

NPJ precision oncology·2026
Same author

Spatial artifact detection improves the reproducibility of drug screening experiments.

iScience·2025
Same author

High-content Image-based Drug Testing of Patients' Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma.

Acta dermato-venereologica·2025
Same author

Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma.

NPJ precision oncology·2025
Same author

Computational drug repurposing: approaches, evaluation of in silico resources and case studies.

Nature reviews. Drug discovery·2025
Same author

Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2024

Related Experiment Video

Updated: Feb 15, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.7K

Methods for High-throughput Drug Combination Screening and Synergy Scoring.

Liye He1, Evgeny Kulesskiy1, Jani Saarela1

  • 1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, PO Box 33, Helsinki, 00014, Finland.

Methods in Molecular Biology (Clifton, N.J.)
|January 19, 2018
PubMed
Summary

Identifying effective cancer therapies requires exploring drug combinations. This study presents a pipeline to screen drug interactions, accelerating the discovery of synergistic treatments to overcome drug resistance and improve patient outcomes.

Keywords:
Computational modelingDrug combinationsExperimental designHigh-throughput screeningSynergy scoring

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.6K
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

9.1K

Related Experiment Videos

Last Updated: Feb 15, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.7K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.6K
Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

9.1K

Area of Science:

  • Oncology
  • Pharmacology
  • Bioinformatics

Background:

  • Aberrantly activated genes in cancer offer therapeutic targets, but single-drug efficacy is limited by resistance.
  • Developing multi-targeted drugs or combinations is crucial for effective cancer treatment and overcoming resistance mechanisms.

Purpose of the Study:

  • To develop and validate an experimental-computational pipeline for high-throughput screening of drug combination effects in cancer cells.
  • To accelerate the identification of synergistic drug interactions for potential anticancer therapeutics.

Main Methods:

  • Implemented an integrated pipeline combining automated high-throughput screening with advanced synergy scoring tools.
  • Utilized computational approaches for robust data analysis of drug combination effects.
  • Screened drug interactions within a specific window of concentrations.

Main Results:

  • Developed a pipeline for efficient and reliable detection of synergistic drug interactions.
  • Demonstrated the capability to identify potential drug combinations for further studies.
  • Accelerated the process of functional profiling for drug combinations.

Conclusions:

  • The developed pipeline facilitates the discovery of effective drug combinations for cancer therapy.
  • This approach aids in overcoming treatment variability and drug resistance.
  • Enables faster identification of synergistic drug interactions for clinical development.